An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Figure 9. A subset of biofilm-associated macrophages express arginase-1. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
CitationFull text
Figure 7. Macrophage migration towards S. aureus biofilms in vivo is limited. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 13. Macrophages exposed to mature S. aureus biofilm exhibit a dystrophic morphology. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 14. Macrophage viability is dictated by invasion into the biofilm proper. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 15. S. aureus biofilms skew macrophage responses to favor bacterial persistence. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 10. S. aureus biofilms skew macrophage gene expression towards an alternatively activated (M2) phenotype. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 3. Visualization of S. aureus biofilm infection using IVIS. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 12. Macrophages recovered from S. aureus biofilm infections harbor viable intracellular bacteria. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 5. S. aureus biofilm attenuates inflammatory mediator expression compared to the wound healing response elicited following sterile catheter implantation. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 2. Evidence of catheter-associated biofilm growth in vivo. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 1. Characterization of S. aureus localization during biofilm development. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 11. Macrophages actively phagocytize planktonic S. aureus but not biofilm-associated bacteria. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 6. S. aureus biofilms elicit exaggerated macrophage infiltrates compared to abscesses. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 8. S. aureus biofilms repress iNOS and augment arginase-1 expression. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Figure 4. Infection with an equivalent S. aureus dose leads to the establishment of catheter-related biofilm infection but rapid clearance from subcutaneous sites. From: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on